首页|期刊导航|中国中西医结合杂志|蓉归化瘀汤联合地诺孕素治疗肾虚血瘀型子宫腺肌症随机对照研究

蓉归化瘀汤联合地诺孕素治疗肾虚血瘀型子宫腺肌症随机对照研究OA

Treatment of Adenomyosis Patients with Shen Deficiency Blood Stasis Syndrome by Ronggui Huayu Decoction with Dienogest:A Randomized Controlled Trial

中文摘要英文摘要

目的 探讨蓉归化瘀汤联合地诺孕素治疗肾虚血瘀型子宫腺肌症的临床疗效.方法 140例均为2024年1-6月在江苏省中西医结合医院妇科就诊的肾虚血瘀型子宫腺肌症患者,134例符合纳入标准.按随机数字表法分为对照组和试验组,每组67例.对照组给予地诺孕素片口服,2 mg/天;试验组在口服地诺孕素基础上,给予蓉归化瘀汤治疗,400 mL/天,早、晚分服;治疗时间均为3个月.检测主要疗效指标(包括痛经评分、月经量评分、中医证候积分及子宫体积大小),次要疗效指标[包括内膜厚度、动脉血流参数及血清糖类抗原125(CA125)、血清肌酸酐磷酸激酶(CK-MM)、可溶性人类白细胞抗原-G(sHLA-G)含量],观察各组不良反应.结果 与本组治疗前比较,两组治疗后痛经评分、月经量评分、中医证候积分、子宫体积、内膜厚度、动脉血流参数及血清学指标均下降(P<0.01).与对照组治疗后比较,试验组痛经评分、月经量评分、中医证候积分、子宫体积、内膜厚度、动脉血流参数及血清CA125、CK-MM、sHLA-G含量均下降(P<0.01).试验组不良反应发生率较对照组低(P<0.01).结论 地诺孕素联合蓉归化瘀汤治疗肾虚血瘀型子宫腺肌症,可改善痛经、月经量过多等临床症状,降低中医证候积分、子宫体积、内膜厚度、动脉血流参数及血清标志物表达等,还能减少地诺孕素治疗导致的阴道不规则出血、潮热等相关不良反应.

Objective To study the clinical efficacy of Ronggui Huayu Decoction(RHD)with dienogest(DNG)in treatment of adenomyosis(AM)patients with Shen deficiency blood stasis syndrome(SDBSS).Methods The 140 patients with SDBSS type AM,all treated at the Gynecology Department of Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine from January to June 2024,met the inclusion criteria.Totally 134 cases were randomly assigned to either the control group or the experimental group using a random number table method,67 patients in each group.Patients in the control group took DNG 2 mg per day,while those in the test group additionally took RHD,400 mL per day.The therapeutic course for all was 3 months.The primary efficacy indicators included dysmenorrhoea score,menstrual volume score,Chinese medicine(CM)syndrome score,and uterine volume.The secondary efficacy indicators included intimal thickness,arterial blood flow parameters and the contents of serum carbohydrate antigen 125(CA125),serum creatine kinase-MM(CK-MM),and soluble human leukocyte antigen-G(sHLA-G).Adverse reactions in each group were observed.Results Compared with before treatment in the same group,the dysmenorrhoea scores,menstrual volume scores,CM syndrome scores,uterine volume,intimal thickness,arterial flow parameters,and serological indicators decreased in the two groups after treatment(P<0.01).Compared with the control group after treatment,the dysmenorrhoea score,menstrual volume score,CM syndrome score,uterine volume,intimal thickness,arterial blood flow parameters,and serum levels of CA125,CK-MM,sHLA-G in the test group were all lower than those in the control group(P<0.01).The incidence of adverse reactions in the test group was lower than those of the control group(P<0.01).Conclusion Treatment of AM patients with SDBSS by DNG+RHD improved clinical symptoms such as dysmenorrhea and excessive menstrual flow,decreased CM syndrome score,uterine volume,the thickness of the endometrium,arterial blood flow parameters,and the expression of serum markers,and also reduced adverse reactions such as irregular vaginal bleeding and hectic fever caused by dienogest.

陈茜;仇影影;黄美华;周文娟;周方芳;万贵平;李桢理;桂涛

南京中医药大学附属中西医结合医院妇产科(南京 210028)南京中医药大学附属中西医结合医院妇产科(南京 210028)||徐州医科大学附属徐州市立医院妇科(江苏 221112)南京中医药大学附属中西医结合医院妇产科(南京 210028)南京中医药大学附属中西医结合医院妇产科(南京 210028)南京中医药大学附属中西医结合医院妇产科(南京 210028)南京中医药大学附属中西医结合医院妇产科(南京 210028)南京中医药大学附属中西医结合医院妇产科(南京 210028)南京中医药大学附属中西医结合医院妇产科(南京 210028)

子宫腺肌症肾虚血瘀证地诺孕素蓉归化瘀汤随机对照试验中药复方

adenomyosisShen deficiency blood stasis syndromedienogestRonggui Huayu Decoctionrandomized controlled trialChinese herbal compound

《中国中西医结合杂志》 2026 (7)

798-805,8

江苏省中医药科技发展计划重点项目(No.ZD202419)江苏省中医药科技发展计划面上项目(No.MS2023039No.MS2023079)

10.7661/j.cjim.20251113.301

评论